Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
FOBI AI Inc. Announces Closing of the Sale of German Subsidiary
June 12, 2025 16:53 ET Â | Source: Fobi AI Inc. Vancouver, BC,…
Ravi Krishnan launches Abler Sports & Entertainment (ASE) to challenge status quo of the sports & entertainment industry
Thursday 12 June, 2025 The IP and data-driven enterprise to focus on…
Green NCAP & CATARC strengthen cooperation in new Working Group & LCA Mutual Recognition Guidelines
LEUVEN, BELGIUM – Today, Green NCAP announces the formation of the Sino-…
Final Call for Entries: Submission Deadline Nears for the Seoul Design Award 2025
SEOUL, South Korea, June 12, 2025 /PRNewswire/ -- The Seoul Design Foundation…
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025
ADJOURNMENT OF THE GENERAL MEETING INITALLY CONVENED ON JUNE 25, 2025 NANTES,…
Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”)…
Wysa Launches AI-Powered Chatbot to Streamline Mental Health Patient Intake in the US
Automated screening cuts patient assessment time by 30 minutes in real-world useBOSTON--(BUSINESS…
Fagron increases share capital through exercise subscription rights
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 – 7PM CET Fagron…
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm,…